Dr. Max Raymond Jr., PIH - Artibonite Region, Haiti

We will soon be finishing up the vaccine campaign with the final dose for children 9 and under. So far, even with delays and the rainy season well upon us, we've reached more than 40,000 people... that's pretty good!

Maybe someday soon we will be here together scaling up the cholera vaccination to the national level with the Haiti Ministry of Health.

In Haiti, PIH's Beatrice Romela speaks at the annual International Nurses Day event.

Jon Lascher, PIH – Artibonite Region, Haiti

We've completed the planned vaccination -- doses 1 and 2 -- for the current phase of the project.

We are very pleased with the results thus far, but we know there are still people we can reach.

Jon Lascher, PIH – Artibonite Region, Haiti

It rained most of the day today limiting our ability to vaccinate large numbers of people. Teams were deployed at different intervals throughout the day in the hopes of vaccinating farmers returning home from the fields in the evening. 

Tomorrow teams will be going door-to-door again.

 

Flag Day celebrates a symbol of Haiti's freedomﾗfrom 1802 to 2012.

Jon Lascher, PIH – Artibonite Region, Haiti

We are pleased to report that during the first two days of delivering the second dose of Shanchol, we vaccinated over 8,000 people. Thanks to Amanda, Jessica and the Majella team for working on a fast solution to a few problems we had yesterday with the tablets. 

Some challenges faced today:

Zanmi Lasante staff and the Belladère community observe the anniversary of a tragic arson attack that killed two beloved members of the ZL family.

Dr. Max Raymond Jr., PIH - Artibonite Region, Haiti

Phase 1, dose 1 of the project is completed and may be considered a success.

Phase 1, dose 2 will begin on Sunday 13th and run through until May 20-22th. Then we'll double back to vaccinate children.

In late April, the final concrete block at the main complex was put into place.

Of the 273,000 women who die in childbirth each year, nearly all could be saved with access to C-sections.